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PD-1, an immune-inhibitory receptor required for immune self-tolerance whose 
deficiency causes autoimmunity with variable severity and tissue specificity 
depending on other genetic factors. PD-1 is expressed on activated T cells, including 
the FoxP3+ Treg cells known to play critical roles in maintaining immune tolerance. 
Yet, whether PD-1 expression by the Treg cells is required for their immune 
regulatory function, especially in autoimmune settings is still unclear. We found that 
mice with partial FoxP3 insufficiency developed early-onset lympho-proliferation and 
lethal autoimmune pancreatitis only when PD-1 is absent. The autoimmune phenotype 
was rescued by the transfer of FoxP3-sufficient T cells, regardless of whether they 
were derived from WT or PD-1-deficient mice, indicating that Treg cells dominantly 
protect from development of spontaneous autoimmunity without intrinsic expression 
of PD-1. The absence of PD-1 combined with partial FoxP3 insufficiency however, 
led to generation of ex-FoxP3 T cells with pro-inflammatory properties and expansion 
of effector/memory T cells that contributed to the autoimmune destruction of target 
tissues. Altogether, the results suggest that PD-1 and FoxP3 work collaboratively in 
maintaining immune tolerance mostly through non-overlapping pathways. Thus, PD-1 
is modulating the activation threshold and maintaining the balance between regulatory 
and effector T cells, while FoxP3 is sufficient for dominant regulation through 
maintaining the integrity of the Treg function. We suggest that genetic or 
environmental factors that even moderately affect the expression of both PD-1 and 






We investigated the effect of PD-1 a negative immunoreceptor on the function of 
FoxP3+ Treg cells. When a moderately down-modulated FoxP3 knockin mouse, which 
did not show any autoimmunity, were made PD-1 deficient, the mice developed severe 
pancreatitis and died soon after birth. PD-1 deficiency also induced instability of Treg 
cell status and increased so-called ex-Treg cells which showed the helper effector 
activity with self antigen recognition. PD-1 deficient T reg cells, however, did not 
compromise their function but rather increased their suppressive activity. Thus, PD-1 





Peripheral immune tolerance is maintained by multiple mechanisms. Activation of T 
cells for example, is regulated by activation-induced cell death, clonal anergy, 
negative costimulation and regulatory T cells (Treg)-mediated suppression, among 
others.  
  Many regulatory pathways are partially redundant, as in the case of the 
costimulatory receptor CTLA-4 and the nuclear factor FoxP3, both inhibiting other T 
cells in a cell-extrinsic fashion. FoxP3 is a hallmark for Treg, driving either 
transcriptional repression or activation of more than 100 targets (1, 2) . FoxP3 directly 
promotes the expression of CTLA-4, a receptor member of the CD28 family (3). 
CTLA-4 suppresses the activation of T cells through competitive binding to CD80 
and CD86 ligands, thus preventing their interaction with the co-activator receptor 
CD28 (3, 4). CTLA-4 also plays a critical role in Treg function. Indeed, deficiency of 
CTLA-4 or FoxP3 in humans causes lethal autoimmunity (5, 6). In mice, genetic 
ablation of CTLA-4 causes a lympho-proliferative disease that phenocopies FoxP3 
deficiency. Moreover, deletion of CTLA-4 specifically on FoxP3+ T cells results in 
autoimmunity and early death of mice (3). These results support the notion that 
CTLA-4 and FoxP3 cooperate for the proper function of Tregs and that both 
molecules need to be co-expressed in T cells to prevent lymphoproliferation (7).  
 
PD-1 is another cell surface receptor belonging to the CD28/CTLA-4 family that 
inhibits activation of T cells. PD-1 has a typical immune receptor tyrosine based 
switch motif (ITSM) (8) in its cytoplasmic tail that is phosphorylated upon 
engagement of PD-1 by its ligands (PD-L1 and PD-L2) (9). The phosphorylated 
ITSM recruits the tyrosine phosphatase SHP-2, leading to dephosphorylation of the 
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antigen receptor complex (10). In this way, PD-1 causes the rheostatic inhibition of 
signaling through TCR, which results in reduced proliferation, cytokine secretion and 
cytotoxic activities of T cells (11, 12). PD-1 contributes to maintaining immune 
tolerance, as autoantigen-specific T cells are maintained in an anergic state in vivo for 
long term in a PD-1 dependent manner (13). Accordingly, the deficiency of PD-1 
causes autoimmunity in mice, and PD-1 is a genetic risk factor in humans and mice, 
albeit with less dramatic outcomes than CTLA-4 or FoxP3 deficiency (14). 
FoxP3+ Treg cells constitutively express PD-1 under diverse conditions, in both 
mice and humans. In fact, Treg cells isolated from mouse germinal centers, as well as 
from chronically HCV-infected patients or cancer patients express high levels of PD-1 
on the surface (15-17). However, the precise role of PD-1 in homeostasis and function 
of Treg cells is still unclear. Its high expression levels suggest that PD-1 acts directly 
on FoxP3+ T cells in a way similar to CTLA-4. Supporting this view, PD-1 
stimulation inhibits IL-2 production by activated T cells and induces anergy, which 
may account for the naturally anergic phenotype of Tregs (18). PD-1 may also 
regulate other aspects of Treg cell biology. Since PD-1 controls the strength of the 
TCR signal, the absence of PD-1 on FoxP3+ T cells may alter the nature of these cells, 
their behavior and function. It is accepted that helper T cells possess remarkable 
plasticity in vivo (19). T helper cells derived from FoxP3+ T cells, generally referred 
to as ex-FoxP3 cells, can be identified using a complex genetic strategy that allows 
for the fate mapping of FoxP3 expressing cells in vivo (20). Unlike Treg cells, the 
ex-FoxP3 cells are rather pathogenic cells with an effector/memory phenotype. Indeed, 
ex-FoxP3 cells were shown to produce inflammatory cytokines and to contribute to 
autoimmunity (20).  
We aimed to elucidate the role of PD-1 and FoxP3 to immune tolerance. For this 
purpose, we bred mice deficient for PD-1 (PD-1 KO) with mice carrying the 
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FoxP3-GFPcre knock-in (KI) locus and Rosa26-tdRFP transgene that can report the 
history of FoxP3 expression (21). Serendipitously, we observed that the 
FoxP3-GFPcre reporter strain showed reduced transcription of FoxP3, which led to 
early death by autoimmune pancreatitis of PD-1 KO mice but not PD-1 sufficient 
mice. The lethal autoimmunity was prevented by the transfer of FoxP3 sufficient Treg 
cells regardless of whether cells were sufficient or deficient for PD-1, indicating that 
PD-1 expression is not required for the suppressive functions of Treg cells. However, 
deficiency of PD-1 affected the Treg compartment by increasing considerably the 
generation of ex-FoxP3 cells and contributing to the expansion of effector/memory T 
cells capable of inducing autoimmunity. Our results indicate that PD-1 regulates the 
relative abundance of Treg and effector T cells to maintain immune tolerance.  
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Results 
Lympho-proliferation and lethal autoimmune pancreatitis in FoxP3-GFPcreKI 
PD-1 deficient mice. We bred PD-1 KO mice with mice carrying the IRES-GFPcre 
reporter knock-in at the 3’ untranslated region of the FoxP3 gene (hereafter 
FoxP3-GFPcreKI) (21) (Fig. S1A). During the course of breeding, we found that some 
of the litters died soon after weaning. The cumulative data revealed that all male mice 
with the genotype of FoxP3-GFPcreKI/Y PD-1 KO died within 3 months of age (Fig. 
1A). Histological analyses revealed the presence of mononuclear infiltrates in multiple 
organs such as the pancreas, liver, lung or heart of FoxP3-GFPcreKI/Y PD-1 KO but 
not FoxP3-GFPcreKI/Y PD-1 WT mice (Fig. 1B, Table S1). Remarkably, the pancreas 
was atrophic and its exocrine structure was almost completely lost in most of the mice 
analyzed. Indeed, the level of serum lipase was significantly reduced in 
FoxP3-GFPcreKI/Y PD-1 KO mice (Fig. S1C). Interestingly, the pancreatic islets 
remained intact in FoxP3-GFPcreKI/Y PD-1 KO mice. The total number of cells and 
frequencies of CD4+ and CD8+ T cells were considerably higher in pancreas and 
pancreatic lymph nodes (LN) (Fig. 1C, Fig. S1D). There was a significant increase in 
CD4+CD44+ and CD8+CD44+ effector/memory T cells, especially in the pancreatic 
LN (Fig. 1C, Fig. S1E). The moribund FoxP3-GFPcreKI/Y PD-1 KO mice did not 
show any kidney or joint pathology as observed previously in PD-1 KO mice on a 
C57BL/6 background (22), probably because the early onset and lethal outcome of 
exocrine pancreatitis. Nephritis and arthritis begin after three months of age (22).  
Examination of lymphoid organs of FoxP3-GFPcreKI/Y PD-1 KO mice revealed 
enlarged spleen (SPL) and LN with significantly increased cellularity (Fig. 1D, Fig. 
S1D). There was a significant increase in frequencies of both CD4+ and CD8+ T cells, 
especially those expressing CD44 in the SPL and LN of FoxP3-GFPcreKI/Y PD-1 KO 
mice compared with those in PD-1 WT mice, indicating a preferential expansion of 
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effector/memory T cell populations (Fig. 1E, Fig. S1F, G). Interestingly, the GFP+ 
(FoxP3+) T cells were also increased in SPL and LN of FoxP3-GFPcreKI/Y PD-1 KO 
mice (Fig. 1E, Fig. S1F, G). The ratios of CD4+CD44+/Treg cells and 
CD8+CD44+/Treg cells were significantly higher in FoxP3-GFPcreKI/Y PD-1 KO mice 
(Fig. 1E, Fig. S1G) indicating that unbalanced T cells expansion with dominance of 
effector/memory T cells versus Treg cells occurs in the absence of PD-1 control.    
Taken together, the analyses revealed that PD-1 deficiency caused 
lympho-proliferation in lymphoid and non-lymphoid organs in FoxP3-GFPcreKI/Y 
mice, resulting in their early death from T cell-mediated autoimmune destruction, 
especially autoimmune pancreatitis. 
 
Transcription of FoxP3 is reduced in the FoxP3-GFPcreKI mice. Two groups 
reported that FoxP3 knock-in reporter mice harboring GFP fused to the 
amino-terminus of FoxP3 (GFP-FoxP3KI) display a partial loss of FoxP3 function, 
promoting autoimmune phenotypes (23, 24). We thought that the current genetic 
modification of the FoxP3 locus could also affect the endogenous FoxP3 expression 
and consequently the function of Treg cells. In the case of GFP-FoxP3 KI mice, the 
transcriptional level of FoxP3 was unaffected, yet the mature GFP-FoxP3 fusion 
protein had altered binding to various cofactors (23, 24). In contrast, our 
FoxP3-GFPcreKI line showed reduced expression of FoxP3 at both transcriptional and 
protein levels, which was more obvious in male FoxP3-GFPKI/Y than in female 
FoxP3-GFPcreKI/WT mice (Fig. 2A, B). The expression of CD25, a marker that usually 
defines activated T cells and Treg cells was reduced on FoxP3+ T cells in lymphoid 
organs from male FoxP3-GFPcreKI/Y mice (Fig. 2C). However, the levels of CTLA-4 
were comparable between FoxP3+CD25+ Treg cells from FoxP3-GFPcreKI/Y mice and 
those from WT mice (Fig. 2C). At the population level, the frequency of CD25+ Treg 
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but not that of CTLA-4+ Treg cells was reduced in male FoxP3-GFPcreKI/Y mice (Fig. 
S2A, B). 
  Importantly, female FoxP3-GFPcreKI/WT PD-1 KO mice were healthy, presumably 
because a half of Treg cells express normal level of FoxP3 transcripts from the WT 
allele (due to random X-inactivation), thus providing a dominant protection (Fig. 1A). 
The allelic difference in FoxP3 expression was represented by higher CD25+ 
expression in GFP- T cells compared with GFP+ T cells in female FoxP3-GFPcreKI/WT 
mice (Fig. S2C). In contrast, the female PD-1 KO mice with the genotype of 
FoxP3-GFPcre KI on both alleles (FoxP3-GFPcreKI/KI PD-1 KO) died with kinetics 
similar to those of male FoxP3-GFPcreKI/Y PD-1 KO (Fig. 1A). Thus, the reduced 
FoxP3 expression in Treg cells is likely contributing to the autoimmune phenotype 
observed in FoxP3-GFPcreKI PD-1 KO mice.  
 
PD-1-deficient Treg cells efficiently rescue the autoimmune phenotype of 
FoxP3-GFPcreKI/Y PD-1 KO mice. To determine if the partial insufficiency of FoxP3 
was the cause of fatal autoimmunity in male FoxP3-GFPcreKI/YPD-1 KO mice, we 
tested whether supplying FoxP3-sufficient Treg cells could rescue the 
FoxP-3-GFPcreKI/Y PD-1 KO mice from death. We transferred CD4+CD25+ T cells 
(>98% of which were Treg cells) sorted from SPL and LN of WT mice into neonatal 
FoxP3-GFPcreKI/Y PD-1 KO mice at day 3 after birth. More than 70% of mice that 
received FoxP3-sufficient Treg cells survived over 3 months without any signs of 
disease (i.e wasting) (Fig. 3A). We next asked whether PD-1 expression on transferred 
Treg cells was needed for such rescue. To address this issue, we performed transfer 
experiments with CD4+CD25+ T cells sorted from PD-1 KO mice. Remarkably, the 
injection of FoxP3-sufficient PD-1-deficient Treg cells prevented the development of 
the wasting disease in FoxP3-GFPcreKI/Y PD-1 KO mice (Fig. 3A). Although we could 
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not directly assess the expansion of transferred Treg cells in this particular system, the 
histological features of the pancreas indicate that PD-1 deficient Treg cells had 
probably enhanced suppressive activity compared to WT Treg cells even 6 months 
after transfer (Fig. 3B). Indeed, while both transfers associated with a significant 
decrease of CD4+ and CD8+ T cells, including the CD44+ effector/memory T cells in 
SPL and LN of the recipient mice, such reduction was much more pronounced in mice 
that received PD-1-deficient Treg cells (Fig. 3C, Fig. S3A). The suppressive function 
of PD-1 deficient Treg cells might be augmented by their accelerated expansion 
and/or due to their increased FoxP3 and CTLA-4 expression (Fig. S3B). Altogether 
the results suggest that Treg cells exert a dominant protection and that PD-1 
expression is not necessary for this protection as long as they maintain FoxP3 
expression at normal or higher levels.  
 
PD-1 deficiency promotes the generation of effector T cells with history of FoxP3 
expression. The above conclusion raises the question as to why PD-1 deficiency 
causes severe autoimmunity in FoxP3-GFPcreKI/Y PD-1 KO mice, in spite of 
generation of Treg cells with increased function. We hypothesized that some Treg 
cells may contribute to the enrichment of effector/memory T cell compartment with 
autoimmune potentials after losing their FoxP3 expression. The breeding of 
FoxP3-GFPcreKI with Rosa26-YFP mice, a CRE-reporter strain allows stable in vivo 
labeling of the cells that once expressed GFP (20). Thus, the GFP-YFP+ cells 
reporting the previous expression of FoxP3 are designated as ex-FoxP3 (20). We took 
advantage of this system and bred FoxP3-GFPcreKI PD-1 KO mice with Rosa26 RFP 
strain, instead of Rosa26-YFP (25)  in order to monitor the development of 
ex-FoxP3 cells in mice with PD-1 deficiency (Fig. S1B). We first compared the effect 
of PD-1 on Treg cells in healthy female FoxP3-GFPcreKI/WT PD-1 KO Rosa-RFP mice. 
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Consistent with a PD-1-deficient phenotype, we observed expansion of Treg cells in 
FoxP3-GFPcreKI/WT Rosa-RFP mice in the absence of PD-1 (Fig. 4A). Since the 
homeostatic control of Treg cell expansion is normally quite solid, such significant 
changes in the frequency of Treg cells suggests the existence of powerful regulatory 
mechanism of Treg cell homeostasis by PD-1.  
  Interestingly, there was a significant increase of CD4+GFP-RFP+ cells (ex-FoxP3) 
in the peripheral lymphoid organs as well as the thymus of heterozygous female 
FoxP3-GFPcreKI/WT mice bearing the Rosa26-RFP transgene and the deletion of PD-1 
compared to the same mice with the WT PD-1 allele (Fig. 4A, B). When activated in 
vitro, sorted GFP-RFP+ex-FoxP3 T cells showed increased production of various 
cytokines compared with GFP+RFP+T cells, confirming previous observations of their 
effector potentials (20) (Fig. 4C). PD-1 deficient ex-FoxP3 secreted higher levels of 
pro-inflammatory (IFN-γ, IL-17A) as well as anti-inflammatory (IL-10) cytokines 
than PD-1-sufficient ex-FoxP3 cells (Fig. 4C). These data clearly indicate that in 
non-inflammatory conditions, PD-1 expression restricts the expansion of Treg cells, 
contributes to maintenance of FoxP3 expression and prevents the generation of 
ex-FoxP3 cells with the powerful effector function.  
 
Ex-FoxP3 cells in PD-1 KO FoxP3-GFPcreKI/Y Rosa-RFP mice contain 
autoreactive cells. We next evaluated the characteristics of Treg cells including the 
generation and effector function of ex-FoxP3 T cells in inflammatory autoimmune 
settings by examining male PD-1 KO FoxP3-GFPcreKI/Y Rosa-RFP mice. Remarkably, 
before the onset of lympho-proliferation, the 2 weeks old pups PD-1 deficient 
fate-mapped mice showed a significant increase in ex-FoxP3 cells compared to the 
PD-1 WT counterparts not only in the SPL and LN but also in pancreatic LN and 
pancreas (Fig. 5A, B). In addition, the frequency of GFP+ cells was increased, but 
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these cells may be of a different nature, as many of them did not express CD25 (Fig. 
5A).  
Interestingly, after the onset of CD4+ T cell expansion and of the autoimmune 
phenotypes, the frequency of ex-FoxP3 T cells became closer to the controls by 
unknown reasons (Fig. 5C). However, the frequency of CD44+GFP-RPF+ ex-FoxP3 T 
cells with effector/memory phenotype was significantly increased in lymphoid tissues 
of PD-1 deficient fate-mapped mice (Fig. 5C). This result clearly shows an increased 
flow of cells that once expressed FoxP3 into the effector/memory T cells 
compartment.  
We next tested the pathogenic potential of ex-FoxP3 T cells from pancreas and 
pancreatic LN of male PD-1 KO FoxP3-GFPcreKI/Y Rosa RFP in vivo, by transferring 
them with or without CD8+ T cells into Rag-2 KO mice. Because only a small number 
of ex-FoxP3 T cells can be isolated from these tissues, we first expanded them in vitro. 
Then, we re-sorted CD4+GFP-RFP+ cells before the transfer, as some of the expanded 
ex-FoxP3 re-expressed FoxP3, as previously reported (21) (Fig. S4A). Interestingly, 2 
weeks after transfer the mice that received ex-FoxP3 T cells, and ex-FoxP3 T cells 
together with CD8+ T cells but not CD8+ T cells alone, began to lose weight and had 
severe diarrhea (Fig. 6A). Mice were examined 4 weeks after the transfer, revealing 
that the large intestine were significantly shorter and swollen in Rag-2 KO mice that 
received ex-FoxP3 T cells or ex-FoxP3 together with CD8+ T cells but not CD8+ T 
cells only (Fig. 6B). Histological analysis confirmed the presence of severe colitis, 
with huge infiltrates of mononuclear cells and disruption of colonic structures only in 
mice receiving ex-FoxP3 T cells alone or the combination of ex-FoxP3 and CD8+ T 
cells (Fig. 6C, Table S2). Similar mononuclear infiltrates were observed in the 
pancreas, especially around pancreatic duct and vessels (Fig. 6C lower panels). 
Unexpectedly, the more pronounced infiltrates were detected in Rag-2 KO mice 
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transferred with ex-FoxP3 T cells only (Fig. 6C lower panels, Table S2). This could be 
due to better expansion of ex-FoxP3 T cells by more abundant IL-2 in the absence of 
competition with CD8+ T cells, as suggested by the increased numbers of ex-FoxP3 
(CD4+) T cells in LN and pancreatic LN in these mice compared to those receiving 
the combination of ex-FoxP3 T cells together with CD8+ T cells (Fig. S4B, C). These 
results clearly indicate that ex-FoxP3 T cells have pathogenic potential and contribute 
to pathology either directly or indirectly by helping other effector T populations, like 
cytotoxic CD8+ T cells. 
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Discussion 
We found that the “genetic surgery” of the FoxP3 locus fortuitously resulted in mildly 
reduced expression of endogenous FoxP3 without obvious functional consequences in 
FoxP3-GFPcreKI mice. However, when crossed with PD-1-deficient mice, the 
FoxP3-GFPcreKI male mice, developed acute and lethal autoimmunity. These mice 
provided a useful model to address how PD-1 modulates the Treg cell biology in 
autoimmune settings. The early death was prevented by the transfer of 
FoxP3-sufficient Treg cells, irrespective of whether they were from WT or 
PD-1-deficient donors.  It should be noted that the Treg cells from PD-1 KO mice 
provided even better rescue compared to Treg cells from WT mice, by causing a 
statistically significant reduction of effector/memory CD4+ and CD8+ T cells. Sage et 
al. have demonstrated that PD-1 restricts the number and the function of follicular 
Tregs (Tfr) (26). Our study expands this finding to conventional Treg cells. FoxP3 
expression and Treg function both require TCR recognition of self-antigens (27, 28). 
We speculate that, as PD-1 attenuates TCR downstream signaling, PD-1 deficiency 
may enhance TCR signaling in Treg cells, which induces their proliferation and in 
turn strengthen their regulatory function in vivo.   
We demonstrated that PD-1 negatively regulates the appearance of ex-FoxP3 cells. 
Previous studies reported the appearance of ex-FoxP3 cells, especially at the 
inflammatory sites such as the pancreatic LN and islets of NOD mice (20), the joints 
in a collagen induced arthritis mouse model (29) and CNS in a EAE model (30). It 
was proposed that the ex-FoxP3 cells derive from genetic reprogramming of 
committed Treg cells (20, 31). On the other hand, Rubtsov et al. showed that FoxP3+ 
Treg cells are stable (32). Beside the two opposing models, Miyao et al. proposed that 
ex-FoxP3 cells did not come from the “genuine” Treg cells, but rather from 
conventional CD4+ T cells that transiently expressed FoxP3 as a consequence of 
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strong self-interaction in vivo (21). We found the increase of ex-FoxP3 cells in the 
PD-1 KO mice in C57BL/6 background, before onset of nephritis or arthritis reported 
in these mice (22). As PD-1 is indisputably an attenuator for antigen receptor 
signaling, possibly PD-1-deficient Tregs would receive stronger TCR stimulation in 
vivo and could convert into FoxP3 negative cells with strong self-reactivity. It is also 
possible that “promiscuous expression” of FoxP3 in conventional T cells is 
augmented in the absence of PD-1, resulting in increase of cells with a history of 
transient FoxP3 expression. We cannot exclude either possibility at this stage. 
In the diseased FoxP3-GFPcreKI PD-1 KO, we initially thought it unlikely that the 
ex-FoxP3 T cells could directly cause autoimmunity. However, at least in the Rag-2 
transfer system, ex-FoxP3 T cells clearly induced autoimmune destruction in the 
pancreas and also in the colon, which was as severe as non-FoxP3 experienced CD44+ 
effector/memory T cells (Fig. S5, Table S2). The presence of CD8+ T cells aggravated 
the autoimmune phenotype in the colon. The targeting of the colon in the Rag-2 KO 
mice but not in the FoxP3-GFPcreKI PD-1 KO mice could be due to a repertoire shift 
of the ex-FoxP3 cells after their activation and skewed expansion in vitro, among 
other possibilities. Taken together, our results indicate that PD-1 signaling maintains 
homeostasis of the Treg cells and the fine-tuned balance between the regulatory and 
effector T cell compartment. Stronger TCR signaling may induce FoxP3 expression 
but could also cause additional transcriptional modifications leading to 
down-regulation and eventually loss of FoxP3 expression, and acquisition of effector 
functions (i.e. cytokine production) by ex-FoxP3 T cells. Such regulation of Treg 
homeostasis is consistent with the feed back control perspective rather than the 
lineage perspective (33). 
It is interesting that even a modest deficiency of FoxP3 expression by Treg cells in 
FoxP3-GFPcreKI mice results in a spontaneous and accelerated autoimmune 
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phenotype with fatal outcome when combined with PD-1 deficiency. PD-1 deficient 
mice developed autoimmune phenotypes, which were strain-specific (12, 22, 34, 35). 
In C57BL/6 background, PD-1 deficiency induced arthritis and nephritis (22), while 
in BALB/c background mostly myocarditis and gastritis (12, 34). Neonatal 
thymectomy in PD-1 KO mice on the BALB/c background was shown to cause lethal 
autoimmune hepatitis, which was attributed to combined deficiency of Treg cells and 
PD-1 (34) . However, thymectomy can cause other effects such as severe 
lymphopenia, which can support autoimmunity. PD-1 deficient MRL strain of mice 
showed rapid and fatal autoimmune myocarditis for undefined reason (35). A mild 
functional deficiency of Treg cells reported in this strain (36) might be synergizing 
with PD-1 deficiency for the development of lethal phenotype. Besides Treg 
instability, reduced FoxP3 expression on Tregs might have caused excessive 
activation of conventional T cells. Under such conditions self-reactive T cells, may 
develop into the effector population. This could be an additive, Treg non-autonomous 
effect of PD-1. In any case, we now show that indeed, deficiency of PD-1 combined 
with even a mild insufficiency of FoxP3+ Treg cells results in an unexpectedly strong 
phenotype. In humans, both polymorphysms of FoxP3 and PD-1 associate to 
autoimmunity. Although the mutations that affect the exon of FoxP3 results in IPEX 
by itself, others mutations affecting intronic or non-coding regions that might alter the 
expression levels are relatively mild (6, 37). The lessons from our mice show that 
even such mild SNPs, if both molecules are affected, can provoke severe 
autoimmunity. It also suggests the requirement of careful immunological monitoring 
of cancer patients who are treated with both anti-CTLA4 and anti-PD-1 antibodies. 
Taken together, our data suggest that PD-1 and FoxP3 work together for 
maintenance of peripheral tolerance, but mostly through different pathways. PD-1 is 
involved in rheostatic modulation of the threshold of TCR signaling that prevents the 
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development of auto-reactive effector T cells and the following tissue destruction, 
while FoxP3 is sufficient for dominant regulation through maintaining the integrity of 
Treg function. Accumulative defects in these independent genetic factors can cause 
life-threatening autoimmune diseases in humans.  
 
 
Materials and Methods 
Animal. All the experiments were carried out using the mice in the C57BL/6 
background. The PD-1 KO, Rosa-RFPKI/WT, and FoxP3-GFPcreKI/Y mice were as 
described previously (21, 25, 38). PD-1 KO mice were initially crossed with reporter 
strains, and resulting F1 generation was extensively intercrossed to obtain PD-1 KO 
in reporter strains. Littermate or the appropriate age/sex-matched mice were used as 
control.  All mice are housed in specific pathogen-free facility, and all procedures 
followed protocols approved by the Animal Research Committee, Graduate School of 
Medicine, Kyoto University. All the other methods and materials are described in 
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Fig. 1.  PD-1 deficient FoxP3-GFPcre mice show lethal autoimmunity. (A) Survival 
curve of male GFPcreKI/Y PD-1 WT (n=20), male GFPcreKI/Y PD-1 KO (n=8), female 
GFPcreKI/WT PD-1 WT (n=20), female GFPcreKI/WT PD-1 KO (n=23), female 
GFPcreKI/KI PD-1 WT (n=11), female GFPcreKI/KI PD-1 KO (n=6) mice. (B) HE 
staining of tissues (magnification 50× and 200×). (C) FACS analysis of pancreas of 
3~10 weeks old FoxP3-GFPcreKI/Y PD-1 WT or PD-1 KO mice. (D) Appearance of 
spleen (SPL) and lymph-nodes (LN). (E) FACS analysis of splenocytes. Data are 
representative of 3~7 mice per group. Bars represent the means (±SEM). ***P<0.001, 
**P<0.01, *P<0.05. 
 
Fig. 2.  Reduced expression of endogenous FoxP3 in FoxP3-GFPcre mice. (A) CD4+ 
cells from SPL and LN of 2~3 months old indicated mice were subjected for 
quantitative real-time PCR (qRT-PCR) for the expression levels of endogenous FoxP3. 
(B) Intracellular staining for FoxP3 gated on LN CD4+ T cells. (C) FACS analysis of 
CD25 and CTLA-4 expression from LN cells of 2 months old male WT or 
FoxP3-GFPcreKI/Y mice. Statistical analysis of CD25 MFI and CTLA-4 MFI from 
SPL and LN of each mouse in indicated genotype. Data are representative of 3~4 
mice per group. Bars represent the means (±SEM). **P<0.01, *P<0.05, ns, not 
significant. 
 
Fig. 3.  PD-1-deficient Tregs efficiently rescue FoxP3-GFPKI/Y PD-1 KO mice from 
lethal autoimmunity. (A) Tregs (CD4+CD25+) were sorted from C57BL/6  PD-1 WT 
or PD-1 KO mice and injected into 3 days old mice as indicated (GFPcreKI/Y PD-1 KO 
+ WT-Treg: n=9; GFPcreKI/Y PD-1 KO + PD-1 KO-Treg: n=9). Mice that did not 
receive Treg cells (GFPcreKI/Y PD-1 WT: n=6; GFPcreKI/Y PD-1 KO: n=5) served as 
controls. (B) HE staining of pancreas from the mice in A. (C) The FACS analysis of 
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SPL from 12~16 weeks old mice in A. (B, C) Note that the data from untreated 
GFPcreKI/Y PD-1 KO is collected at 3~10 weeks old due to early death of this group. 
Data are representative of 4~6 mice per group. Bars represent the means (±SEM). 
**P<0.01, *P<0.05, ns, not significant. 
 
Fig. 4.  The increase of ex-FoxP3 T cells in female FoxP3-GFPcreKI/WT PD-1 KO 
mice. (A) GFP and RFP expression from spleen of 4~8 weeks old FoxP3-GFPcreKI/WT 
Rosa-RFP PD-1 KO mice. (B) Percent GFP−RFP+ (ex-FoxP3) T cells within RFP+ T 
cells (Treg plus ex-FoxP3) of CD4+ T cells, or CD4-CD8+ thymocytes (Thy). (C) The 
same number of naïve, GFP+RFP+ and GFP-RFP+ of CD4+ T cells were sorted from 
mice in A, and stimulated with phorbol 12-myristate 13-acetate (PMA) and ionomycin, 
the level of cytokine was measured. Data are shown from 3~6 mice per group. Bars 
represent the means (±SEM). ***P<0.001, **P<0.01, *P<0.05. 
 
Fig. 5.  ex-FoxP3 T cells in autoimmune FoxP3-GFPcreKI/Y PD-1 KO mice. 
(A) FACS analysis of Tregs, ex-FoxP3 T cells, and CD25+ T cells from SPL of 2 
weeks old male FoxP3-GFPcreKI/Y PD-1 KO mice. (B) Statistical analysis of the 
ex-FoxP3 (GFP-RFP+) cells within RFP+ T cells in A. (C) FACS analysis of SPL cells 
from 3~7 weeks old male FoxP3-GFPcreKI/Y Rosa-RFP PD-1 KO mice. Data are from 
3~6 mice per group. Bars represent the means (±SEM). **P<0.01, *P<0.05. 
 
Fig. 6.  ex-FoxP3 T cells contain autoreactive cells with pathogenic potential. (A) 
CD8+, ex-FoxP3 or the combination of CD8+ and ex-FoxP3 (1:1) T cells from 
pancreatic LN and pancreas of FoxP3-GFPcreKI/Y Rosa-RFP PD-1 KO mice were 
transferred into Rag-2 KO mice (See supplementary materials and methods). Body 
weight was monitored for 4 weeks. The data is shown as a ratio of weight before 
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injection. Statistical analysis was performed at 4 weeks. (B) large intestine of the 
recipients at 4 weeks. (C) HE staining of large intestine and pancreas of mice in B 
(magnification 50× and 200×). Representative data of 3~4 mice per each group are 
shown. Bars represent the means (±S.D.). ***P<0.001, *P<0.05. 
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SI Materials and Methods 
Antibodies and Reagents. The antibodies conjugated with various fluorophores for 
flow cytometry included CD4 (clone: GK1.5), CD8 (53-6.7), CD25 (PC61.5), CD44 
(1M7). The intracellular staining for CTLA-4 (UC10-4B9) and FoxP3 (FJK-16s) was 
performed by FoxP3 intracellular staining kit (e-Bioscience). For cytokine detection, 
cells were stimulated with 50ng/ml PMA and 500ng/ml ionomycin for 3 days, and the 
supernatant was measured by the mouse Th1/Th2/Th17 Cytokine Kit (BD).  
Quantitative RT-PCR.  Total RNA was extracted by RNeasy Mini Kit (QIAGEN) 
and reverse-transcribed using reagents included in the QuantiTectTM SYBR Green RT-
PCR Master Mix (QIAGEN). 7500 Fast Real-Time PCR system (Applied 
Biosystems) was used for real-time PCR. Gene expression was normalized to the 
Gapdh expression. The following primers were used: FoxP3 forward 5’-
GGCCCTTCTCCAGGACAGA-3’;  reverse 5’-GCTGATCATGGCTGGGTTGT-3’ 
(39). 
Adoptive transfer. SPL and LN cells were isolated from PD-1 WT or PD-1 KO mice, 
CD4+ T cells were enriched by CD4 micro-beads and autoMACS (Miltenyibiotec), 
then 1x106 Treg (CD4+CD25+) cells were further sorted on FACSAriaTMII (BD 
Sciences) and injected intra-peritoneally into FoxP3-GFPcreKI/Y PD-1 KO male mice 
at day 3 after birth. For Rag-2 KO mice transfer experiment, CD8 T cells and ex-
FoxP3 (GFP-RFP+) cells were sorted from pancreatic LN and pancreas of male 
FoxP3-GFPcreKI/Y Rosa-RFPKI/WT PD-1 KO mice, and expanded in vitro by 
2 
Dynabeads mouse T-Activator CD3/CD28 (VERITAS) in the present of recombinant 
human IL2 (PEPROTECH), after 10 days’ culture, each group of cells was sorted 
again, then 1x106 CD8+, ex-FoxP3 or the combination of CD8+ and ex-FoxP3 (1:1) T 
cells were transferred intravenously into Rag-2 KO mice.  
Preparation of mononuclear cells from pancreas. The tissue was cut into about 3-5 
mm thick pieces and incubated 30 min in RPMI 1640 medium (life technologies, 
serum free) with 0.25 mg/ml DNAse I (Roche) and 2 mg/ml collagenase D (Roche) at 
37oC on a rotator. The tissue was dissociated with a P1000 by pipetting 20 times (need 
to cut tip) and incubated 10 min at 37oC on a rotator, then the tissue was further 
dissociated with a P1000 by pipetting 20 times (uncut tip). Digested tissue was 
washed twice with RPMI 1640 medium (2% (v/v) FBS) and strained through a 70µm 
cell strainer (greiner bio-one). Cells were analyzed in a flow cytometer (FACSCantoII, 
BD Biosciences). 
Statistical analysis. The survival curves were compared using a log-rank test and 
means of groups were analyzed by two-tailed Student’s t-test or One-way ANOVA. P 
values <0.05 were considered significant. 
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SI Figure Legend 
Fig. S1.  Schematic representation of reporter mice and lympho-proliferation of 
FoxP3-GFPcreKI/Y PD-1 KO mice. (A) Map of FoxP3-GFPcre locus is shown. Filled 
boxes, exons; gray box, 3’UTR of Foxp3 gene; I, IRES. (B) Principle of Cre-Lox-
mediated tdRFP. (C) 3~11 weeks old male FoxP3-GFPcreKI/Y PD-1 WT or PD-1 KO 
mice were analyzed for serum lipase concentration (excluding the maximum and 
minimum values). (D) Total number of mononuclear cells in pancreas, pancreatic LN, 
SPL and LN of 3~10 weeks old FoxP3-GFPcreKI/Y PD-1 WT or PD-1 KO mice. (E) 
The number of CD4+ and CD8+ T cells from pancreas and pancreatic LN, and the 
number of CD44+ in CD4+ or CD8+ T cells from pancreatic LN of mice as in D. (F) 
The number of CD4+, CD8+, CD44+CD4+, CD44+CD8+ and FoxP3+(GFP+) T cells 
from spleen of mice as in D. (G) LN cells were analyzed for the frequency and 
number of CD4+, CD8+, CD44+CD4+, CD44+CD8+, FoxP3+ (GFP+) T cells, and for 
the ratio of CD44+ (gated on CD4+ or CD8+ T cells) and FoxP3+ (GFP+) T cells of 
mice as in D. Data are representative of 3~7 mice per group and shown as the means 
(±SEM). ***P<0.001, **P<0.01, *P<0.05. 
Fig. S2.  CD25+ T cells are decreased in FoxP3-GFPcre mice. (A) FACS analysis of 
LN cells from 2~3 months old male WT or FoxP3-GFPcreKI/Y mice for expression of 
FoxP3, CD25 and CTLA-4 gated on CD4+ T cells. Numbers in plots indicate percent 
cells in each gate. (B) Statistical analysis of FoxP3+CD25hi frequency and cell number 
in CD4+ T cells (left panel), and FoxP3+CTLA-4+ frequency and cell number in CD4+ 
T cells (right panel) from SPL and LN of mice as in A. (C) Statistical analysis of 
CD25 MFI within CD25+GFP- or CD25+GFP+ T cells from SPL and LN of female 
FoxP3-GFPcreKI/WT mice. Data are representative of 3~4 mice per group. Bars 
represent the means (±SEM). ***P<0.001, **P<0.01, *P<0.05, ns, not significant. 
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Fig. S3.  PD-1 deficient Treg cells showed increased CTLA-4 expression and 
suppressive activity in vivo. (A) The number of CD4+, CD8+, CD44+CD4+ and 
CD44+CD8+ T cells in LN from indicated mice as in Fig. 3C. (B) FACS analysis of 
FoxP3 and CTLA-4 expression gated on CD4+ T cells from SPL and LN of 2 months 
old PD-1 WT or PD-1 KO mice on the C57BL/6 background. Numbers in plots 
indicate percent cells in each gate. Data are representative of 3~6 mice per group. 
Bars represent the means (±SEM). ***P<0.001, **P<0.01, *P<0.05, ns, not 
significant. 
Fig. S4.  PD-1 deficient CD8 and ex-FoxP3 transferred Rag-2 KO mice. (A) Before 
transfer, CD8+ and ex-FoxP3 T cells as in Fig. 6A, were re-sorted and analyzed for 
FACS. (B) FACS analysis of CD8 and ex-FoxP3 expression in SPL, LN and 
pancreatic LN of Rag-2 KO mice 4 weeks after transfer of each indicated cells. (C) 
The absolute number of ex-FoxP3 T cells in SPL, LN and pancreatic LN of mice as in 
B. Numbers in plots indicate percent cells in each gate. Representative data of 3~4 
mice per each group are shown. Bars represent the means (±SEM). **P<0.01, 
*P<0.05.
Fig. S5.  Proinflamatoy activites of PD-1 deficient CD44+RFP- T cells in Rag-2 KO 
mice. (A) CD8+ and CD44+RFP-GFP-CD4+ (CD44+RFP-) T cells were sorted from 
pancreatic LN and pancreas of male FoxP3-GFPcreKI/Y Rosa-RFP PD-1 KO mice, and 
expanded in vitro by CD3/CD28-beads in the present of IL2 for 10 days, each group 
of cells was re-sorted and CD44+RFP- or the combination of CD8+ and CD44+RFP- 
(1:1) T cells were respectively transferred into Rag-2 KO mice. Body weight was 
monitored during the 3~4 weeks of each group of mice. The mean weight is shown as 
5 
a ratio of weight before injection. Statistical analysis was performed between each 
group after 3 weeks injection. (B) Picture of large intestine of Rag-2 KO mice 
transferred with indicated cells for 3 or 4 weeks. (C) HE staining of large intestine and 
pancreas of mice as in B (magnification 50×, 200× and 400×). Mitosis in crypt is 
marked by red circle. Representative data of 3~4 mice per each group are shown. Data 
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Table S1. Histological examination of mice. 
Genotype Age Pancreas Lung Liver Salivary Heart 
38 0 0 0 0 0 
FoxP3- 38 0 0 0 0 0 
GFPcreKI/Y 42 0 1 0 0 0 
PD-1 WT 47 0 0 0 ND ND 
71 0 1 0 0 0 
71 0 1 0 0 0 
80 1 0 0 0 0 
38 1 1 0 0 0 
FoxP3- 38 4 0 1 0 0 
GFPcreKI/Y 47 3 1 1 ND ND 
PD-1 KO 42 4 1 1 0 0 
56 4 1 1 0 1 
71 3 1 1 0 1 
71 4 1 1 1 1 
Table summarizes the score of inflammation of organs from 
male FoxP3-GFPcreKI/Y PD-1 WT or male FoxP3-GFPcreKI/Y 
PD-1 KO mice at the indicated age (days). Score 0: absence of 
lymphocytic infiltrates; Score 1: mild infiltrates; Score 2: 
moderate infiltrates; Score 3: marked infiltrates; Score 4: 
almost complete destruction of organs. ND, not done. 
Table S2. Histological examination of Rag-2 KO mice with adoptive transfer. 
Organ Donor cells Score 
CD8+ 0~1 
Large ex-FoxP3 2~3 
intestine ex-FoxP3 + CD8+ 3 
CD44+RFP- 3 
CD44+RFP- + CD8+ 4 
Inflammatory cell 
Organ Donor cells infiltration in the Insulitis 
exocrine pancreas  
CD8+ 0~1 0 
ex-FoxP3 2 0~1 
Pancreas ex-FoxP3 + CD8+ 1 0~1 
CD44+RFP- 3 1 
CD44+RFP- + CD8+ 1~2 0~1 
Table summarizes the score of inflammation of Large intestine and pancreas 
from Rag-2 KO mice 3 weeks after transfer of the combination of CD44+RFP- + 
CD8+, or 4 weeks after transfer of other indicated T cells from pancreatic LN and 
pancreas of male FoxP3-GFPcreKI/Y Rosa-RFP PD-1 KO mice. Score 0: normal 
colon mucosa or absent of lymphocytic cell infiltration; Score 1: mild mucosal 
changes or mild infiltrates; Score 2: mucosal abrasion or moderate infiltrates; 
Score 3: mucosal erosion, ulceration or marked infiltrates; Score 4: mucosa 
atrophy and few mitosis in crypt, or almost complete destruction of organs. 
